Teva (TEVA) Shares Volatile as CEO Comments on Outlook: Sees $31B in Sales, $6.8B in Net Income by 2014
Tweet Send to a Friend
Speaking on a webcast with analysts, Teva Pharma's (Nasdaq: TEVA) President and CEO, Shlomo Yanai, is making some headlines:
...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
